Reply by Authors
J Urol
.
2022 Dec;208(6):1239.
doi: 10.1097/JU.0000000000002902.04.
Epub 2022 Dec 1.
Authors
Brian De
1
,
Dario Pasalic
1
,
Daniel A Barocas
2
,
Christopher J D Wallis
3
,
Li-Ching Huang
4
,
Zhiguo Zhao
4
,
Tatsuki Koyama
4
,
Chad Tang
1
,
Michael Goodman
5
,
Ann S Hamilton
6
,
Xiao-Cheng Wu
7
,
Lisa E Paddock
8
,
Antoinette Stroup
8
,
Matthew R Cooperberg
9
,
Mia Hashibe
10
,
Brock B O'Neil
11
,
Sherrie H Kaplan
12
,
Sheldon Greenfield
12
,
David F Penson
2
13
,
Karen E Hoffman
1
Affiliations
1
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
2
Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
3
Division of Urology, Department of Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
4
Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
5
Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, Georgia.
6
Department of Preventive Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, California.
7
Department of Epidemiology, Louisiana State University New Orleans School of Public Health, New Orleans, Louisiana.
8
Department of Epidemiology, Cancer Institute of New Jersey, Rutgers Health, New Brunswick, New Jersey.
9
Department of Urology, University of California San Francisco, San Francisco, California.
10
Department of Family and Preventive Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
11
Department of Urology, University of Utah Health, Salt Lake City, Utah.
12
Department of Medicine, University of California Irvine, Irvine, California.
13
Geriatric Research Education and Clinical Center, Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee.
PMID:
36349918
DOI:
10.1097/JU.0000000000002902.04
No abstract available
Publication types
Comment